Showing results (71-80 of 220) with videos related to
Sort By:
Pageof 22
Annals of Internal Medicine|February 1, 1983
Evaluation of tamoxifen doses with and without fluoxymesterone in advanced breast cancerD C Tormey, M E Lippman, B K Edwards, et al.Cancer|August 15, 1980
Biologic markers in breast carcinoma: clinical correlations with urinary polyaminesD C Tormey, T P Waalkes, K C Kuo, et al.Cancer Research|February 15, 1988
Endocrine status of premenopausal node-positive breast cancer patients following adjuvant chemotherapy and long-term tamoxifenP M Ravdin, N F Fritz, D C Tormey, et al.Cancer Clinical Trials|January 1, 1981
Adriamycin plus vincristine alone or with dibromodulcitol or ICRF-159 in metastatic breast cancerF J Cummings, R Gelman, D C Tormey, et al.Journal of the National Cancer Institute|September 1, 1978
Serum protein-bound carbohydrates for following the course of disease in patients with metastatic breast carcinomaT P Waalkes, J E Mrochek, S R Dinsmore, et al.Clinical Chemistry|September 1, 1976
Protein-bound carbohydrates in breast cancer. Liquid-chromatographic analysis for mannose, galactose, fucose, and sialic acid in serumJ E Mrochek, S R Dinsmore, D C Tormey, et al.Cancer Research|June 1, 1985
Phase I clinical study with pharmacokinetic analysis of 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193) administered as a five-day infusionD L Trump, K D Tutsch, J M Koeller, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Long-term survival of patients treated with combination chemotherapy for metastatic breast cancerG Falkson, D C Tormey, P Carey, et al.Cancer|June 1, 1977
Biological markers in breast carcinoma. III. Clinical correlations with carcinoembryonic antigenD C Tormey, T P Waalkes, J J Snyder, et al.Experimental Hematology|November 1, 1975
Amplification of colony stimulating activity in human serum by interaction with CSA from other sourcesJ Mabry, P P Carbone, J M BullPageof 22